American Healthcare REIT Director Awarded 3,042 Restricted Shares
American Healthcare REIT (NYSE:AHR) filed a Form 4 reporting a routine insider transaction.
Rhea-AI Filing Summary
American Healthcare REIT (NYSE:AHR) filed a Form 4 reporting a routine insider transaction. Director Marvin R. O'Quinn was granted 3,042 shares of restricted common stock on June 25, 2025 upon his re-election to the board. The grant carries a cost basis of $0 and is scheduled to vest on June 25, 2026. Following the award, O'Quinn’s beneficial ownership increases to 18,062 shares. No shares were sold or disposed of, and the filing does not reference a Rule 10b5-1 trading plan. The disclosure represents typical board compensation and does not indicate any material change in insider sentiment or the company’s financial condition.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small, routine stock grant—neutral signal for investors.
The Form 4 documents a standard director equity award rather than an open-market buy or sell. At 3,042 shares (total ownership now 18,062), the increment is modest and below thresholds that typically move markets. Such grants modestly align director incentives with shareholders but convey no directional view on valuation. Absent price disclosure or unusual size, the filing is neutral to the investment thesis and unlikely to affect liquidity or governance risk profiles.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 3,042 | $0.00 | $0.00 |
Footnotes (1)
- F1. Upon his re-election as a director to the board of directors of the Issuer on June 25, 2025, the Reporting Person was granted 3,042 shares of restricted common stock on June 25, 2025. The reported shares of restricted common stock vest on June 25, 2026.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is Marvin O'Quinn’s total ownership in AHR after the reported grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.